Oliver Brooks

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Jefferson M. Jones, Katherine E. Fleming-Dutra, Mila M. Prill et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 304 citations · Full text

Respiratory Virus Immunity, Respiratory Complications, Pediatric Lung Disease +20

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023

Katherine E. Fleming-Dutra, Jefferson M. Jones, Lauren E. Roper et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 237 citations · Full text

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021

Sarah Mbaeyi, Sara E. Oliver, Jennifer P. Collins et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 173 citations · Full text

Immunodeficiencies, Immunology, Covid-19 Vaccines +22

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Kate R. Woodworth, Danielle Moulia, Jennifer P. Collins et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 167 citations · Full text

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

Hannah G. Rosenblum, Megan J. Wallace, Monica Godfrey et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 154 citations · Full text

Vaccine Research, Immunology, Immunodominance +21